Given the significance attributed to hsa-miR-103a-3p and hsa-miR-107 in glioma, as elucidated by pertinent literature, we proceeded to investigate the relationship between LAPTM4A expression and these two miRNAs in glioma (Supplementary Figure 9C). This evidence concerns the gene LAPTM4A and central nervous system cancer.